uniQure Announces Company Presentation at Jefferies Healthcare Conference
June 01 2017 - 7:00AM
Live webcast on Friday, June 9,
2017 at 08:00 am EDT
LEXINGTON, Mass. and AMSTERDAM,
the Netherlands, June 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V.
(NASDAQ:QURE), a leading gene therapy company advancing
transformative therapies for patients with severe medical needs,
today announced that it will present a corporate overview and host
investor meetings during the Jefferies Healthcare Conference, held
in New York City, from June 6 - 9, 2017.
Matt Kapusta, chief executive
officer, will present on Friday, June 9, 2017 at 8:00 am EDT.
The live webcast of the presentation can be accessed through
the link displayed in the Investor Section of uniQure
website
at http://uniqure.com/investors-newsroom/events-presentations.php.
A replay of the webcast will be available within 24 hours following
the event, and will remain available for at least two weeks.
About
uniQure
uniQure is delivering on the promise of gene therapy - single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with hemophilia, Huntington's disease and cardiovascular
diseases. www.uniQure.com
uniQure Contacts:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: uniQure N.V. via Globenewswire
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024